<?xml version="1.0" encoding="UTF-8"?>
<p>There are no approved RNA vaccines to date, as toxicity cannot always be predicted from animal studies due to species differences between human and animals [
 <xref rid="B55-pathogens-09-00430" ref-type="bibr">55</xref>]. Some effects seen in previous RNA-based vaccinations have been pancreatitis, lactic acidosis, liver steatosis, nerve damage, and death [
 <xref rid="B55-pathogens-09-00430" ref-type="bibr">55</xref>]. Liver toxicity was reported in preclinical studies using RNA therapy for Criglerâ€“Nayjor syndrome, and in an RNA-based rabies vaccination trial, an increased and deleterious inflammatory response ended the trial [
 <xref rid="B55-pathogens-09-00430" ref-type="bibr">55</xref>]. This is possibly due to type 1 interferon induction by RNA, which is known to induce autoimmune diseases [
 <xref rid="B55-pathogens-09-00430" ref-type="bibr">55</xref>]. DNA-based vaccines have also been implicated in inducing an innate immune response through toll-like receptor (TLR) 9 and non-TLR activation [
 <xref rid="B56-pathogens-09-00430" ref-type="bibr">56</xref>].
</p>
